Coronavirus Stocks: Take a Breather-The Easy Trades Have Been Done
Coronavirus Stocks-Take a Breather the Easy Trades Have Been Made Biotech Bull Market is Intact but Look to Rebalancing and Raising Cash COVID Risks are Rising and Economic Recovery is Pushed Out Work at Home Theme Boosts New Software and Telemedicine Access...
Volatile Week for Coronavirus Stocks: COVID Vaccines are in Focus…Update-5
Update-5 JY 7 After close with NASDAQ down 0.86%, but biotechs hold. Genmark (GNMK) up 10.33% AH to $17.22 on Preliminary q2 Results. Revs of $40.1M, a 118% increase over Q2 2019, Placed 71 new ePlex analyzers for a total installed base of 650. Added to VIR Bio (VIR) up 8.12% to $44.35.Also...
Biotech Breakout -XBI: Portfolio Notes and Composition Update-3
Update-3...June 25-Re-opening Paused in FLA and TX-but stocks rally anyway. NASDAQ leads up 11% YTD. Trading remains volatile e.g. VIR. Bullish trend intact for biotech IBB up 1.11%. Vaccine stocks continue strong: BNTX INO NVAX ; MRNA lagging. Diagnostic leaders today: GNMK up 10.28%, QDEL up...
What’s Next for Coronavirus Stocks? Diagnostics are the Near Term Focus…Update-2
Update-2 6/20...Strong finish for biotech on Friday with XBI up 2.83% to $108.85, up 5.64% for week; and one year high. Coronavirus strong stocks for the week: GNMK HOLX NVAX RGEN TDOC VIR . Quidel (QDEL) rests at $210 handle after rocketing from $170 level on June12. GILD made a big move...
Momentum Trading Shifts to Cyclicals and Industrials but Biotech is in For the Long Run…Update-3 Steroid treatment for COVID!
Update-3 6/16/20 at opening...Futures up on 18% increase in Retail Sales and New Potential coronavirus treatment-Dexamethasone. Low dose steroid treatment is a major breakthrough and can save lives. Coronavirus stocks take a hit: GNMK INO MRNA QDEL, but XBI up 1.79%. Update at the close as...
